Literature DB >> 2823270

Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.

K B Tan1, M R Mattern, R A Boyce, P S Schein.   

Abstract

A human Burkitt lymphoma cell line, Raji-HN2, made 10-fold more resistant to nitrogen mustard (HN2) than the parental Raji cell line, exhibited the following characteristics when compared to the parental Raji cells: (i) decreased HN2-induced DNA interstrand crosslinking; (ii) increased (3-fold) DNA topoisomerase II [DNA topoisomerase (ATP-hydrolyzing), EC 5.99.1.3] activity; (iii) increased (4- to 11-fold) sensitivity to topoisomerase II inhibitors; (iv) increased (2-fold) glutathione content; and (v) increased (2-fold) cell doubling time. The resistant phenotype was unstable and was maintained by weekly treatment of the cells with HN2. Growing the resistant cells in the absence of HN2 resulted in a time-dependent decrease in both resistance to HN2 and topoisomerase II activity and an increase in DNA interstrand crosslinking induced by HN2. We hypothesize that HN2 resistance is due to enhanced monoadduct repair with resultant decreased DNA crosslinking and that this process is mediated by topoisomerase II.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823270      PMCID: PMC299361          DOI: 10.1073/pnas.84.21.7668

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  The initial clinical trial of nitrogen mustard.

Authors:  A GILMAN
Journal:  Am J Surg       Date:  1963-05       Impact factor: 2.565

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links.

Authors:  W E Ross; R A Ewig; K W Kohn
Journal:  Cancer Res       Date:  1978-06       Impact factor: 12.701

4.  Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases.

Authors:  L F Liu; J L Davis; R Calendar
Journal:  Nucleic Acids Res       Date:  1981-08-25       Impact factor: 16.971

5.  A homogeneous type II DNA topoisomerase from HeLa cell nuclei.

Authors:  K G Miller; L F Liu; P T Englund
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

6.  DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells.

Authors:  L C Erickson; G Laurent; N A Sharkey; K W Kohn
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

Review 7.  Glutathione metabolism as a determinant of therapeutic efficacy: a review.

Authors:  B A Arrick; C F Nathan
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

8.  DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.

Authors:  S DiNardo; K Voelkel; R Sternglanz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains.

Authors:  R S Day; C H Ziolkowski; D A Scudiero; S A Meyer; A S Lubiniecki; A J Girardi; S M Galloway; G D Bynum
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

10.  Human lymphoblasts contain DNA glycosylase activity excising N-3 and N-7 methyl and ethyl purines but not O6-alkylguanines or 1-alkyladenines.

Authors:  B Singer; T P Brent
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  15 in total

1.  DNA topoisomerase II alpha is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2.

Authors:  S Taagepera; P N Rao; F H Drake; G J Gorbsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 2.  Topoisomerases, new targets in cancer chemotherapy.

Authors:  J G Zijlstra; S de Jong; E G de Vries; N H Mulder
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes.

Authors:  T D Chung; F H Drake; K B Tan; S R Per; S T Crooke; C K Mirabelli
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Nitrogen mustard inhibits transcription and translation in a cell free system.

Authors:  A Masta; P J Gray; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-09-11       Impact factor: 16.971

5.  Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.

Authors:  D S Tews; A Nissen; C Külgen; A K Gaumann
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

6.  Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline.

Authors:  J P Eder; B A Teicher; S A Holden; L Senator; K N Cathcart; L E Schnipper
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia.

Authors:  W R Waud; S D Harrison; K S Gilbert; W R Laster; D P Griswold
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

8.  Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin.

Authors:  A Gaumann; D S Tews; T Mentzel; P K Petrow; E Mayer; M Otto; C J Kirkpatrick; J Kriegsmann
Journal:  Virchows Arch       Date:  2003-05-13       Impact factor: 4.064

9.  Molecular basis of nitrogen mustard effects on transcription processes: role of depurination.

Authors:  A Masta; P J Gray; D R Phillips
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

10.  Structure-based design, synthesis and biological testing of etoposide analog epipodophyllotoxin-N-mustard hybrid compounds designed to covalently bind to topoisomerase II and DNA.

Authors:  Arun A Yadav; Xing Wu; Daywin Patel; Jack C Yalowich; Brian B Hasinoff
Journal:  Bioorg Med Chem       Date:  2014-09-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.